{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:27:21Z","timestamp":1759991241769},"reference-count":17,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jagp.2019.08.012","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T15:49:12Z","timestamp":1566229752000},"page":"1428-1432","source":"Crossref","is-referenced-by-count":5,"title":["The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Christopher","family":"Randolph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2019.08.012_bib0001","doi-asserted-by":"crossref","unstructured":"Patrick RE, Hobbs, K, Mathias, L, et al. The limitations of using cognitive cutoff scores for enrollment in Alzheimer's trials. Am J Geriatr Psychiatry, 2019;10:1153-1158.","DOI":"10.1016\/j.jagp.2019.02.014"},{"key":"10.1016\/j.jagp.2019.08.012_bib0002","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2019.08.012_bib0003","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2019.08.012_bib0004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.acn.2004.11.002","article-title":"Norming subjects for the Halstead Reitan battery","volume":"20","author":"Russell","year":"2005","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.jagp.2019.08.012_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2019.08.012_bib0006","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.0000000000001877","article-title":"Amyloid-\u03b2 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials","volume":"85","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.08.012_bib0007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jagp.2019.08.012_bib0008","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.08.012_bib0009","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jagp.2019.08.012_bib0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/arclin\/acr039","article-title":"Sensitivity and test-retest reliability of the international shopping list test in assessing verbal learning and memory in mild Alzheimer's disease","volume":"26","author":"Thompson","year":"2011","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.jagp.2019.08.012_bib0011","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/01688639708403750","article-title":"Free and cued selective reminding and selective reminding in the elderly","volume":"19","author":"Grober","year":"1997","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.jagp.2019.08.012_bib0012","series-title":"Wechsler Memory Scale\u2014Fourth Edition (WMS\u2013IV)","author":"Wechsler","year":"2009"},{"key":"10.1016\/j.jagp.2019.08.012_bib0013","series-title":"Repeatable Battery for the Assessment of Neuropsychological Status","author":"Randolph","year":"1998"},{"key":"10.1016\/j.jagp.2019.08.012_bib0014","series-title":"Wechsler Memory Scale\u2014Fourth Edition (WMS\u2013IV) Technical and Interpretive Manual","author":"Wechsler","year":"2009"},{"key":"10.1016\/j.jagp.2019.08.012_bib0015","series-title":"New Research Presented in Poster Format at the Alzheimer's Association International Conference","article-title":"Cross-cultural applicability of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in cognitively normal subjects","author":"Randolph","year":"2019"},{"key":"10.1016\/j.jagp.2019.08.012_bib0016","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jagp.2019.08.012_bib0017","unstructured":"Negash S, Weber CJ, Randolph C: Clinical and amyloid screen failure rates in episodic memory measures in early AD trials, In: New Research Presented in Poster Format at theClinical Trials of Alzheimer's Disease (CTAD) meeting, Barcelona, Spain 2019"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748119304750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748119304750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T15:38:47Z","timestamp":1573659527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748119304750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1064748119304750"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2019.08.012","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}